The specific interaction between biotin and avidin (streptavidin) makes it an excellent tool to facilitate the detection, purification, and immobilization of the proteins.

This versatile technology is adopted in a diverse range of applications:

  • ELISA for protein quantification,
  • FACS to detect/isolate cells,
  • Biopanning for the selection of phage display,
  • SPR to study protein binding kinetics,
  • Immuno-capture and Enrichment to isolate antibodies from plasma or other biological fluid.

However high quality biotinylated proteins presents a major challenge to generate. To overcome the technical issues as insufficient labeling, high batch-to-batch variation, and unpredictable performance, ACROBiosystems has developed an exclusive collection of pre-labeled and experimentally validated biotinylated recombinant proteins. The MABsol® biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins. These high quality recombinant proteins are closest to natural conformation and modification as starting materials. The biotinylated protein collection includes two unique and complimentary product series:

1. PrecisionAvi series with ready-to-use Avitag™ technology – a unique 15 amino acid peptide

Série PrecisionAvi avec technologie Avitag™ This single-point enzymatic labeling technique brings many advantages for commonly used binding assays.

  • The biotinylation only happens on the lysine residue of Avitag.
  • NO interference with the target protein’s natural binding activities.
  • The protein orientation is uniform when immobilized on an avidin-coated surface.


2. UltraLys series with in-house developed chemical biotin labeling method for Ultra detection sensitivity

Série UltraLys avec méthode de marquage chimique à la biotine
  • Higher detection sensitivity
  • In-house developed chemical labeling approach


Key Features

1. Closest to Natural Conformation and Modification

The production of the biotinylated proteins is carried out using the proprietary HEKMax® expression platform. As expression hosts, the human HEK293 cells have a variety of advantages compared to other cell types as summarized in the table below.

Expression systems Folding Phosphorylation Proteolytic processing Glycosylation
E. Coli + N/A N/A N/A
Insect Cell ++ ++ ++ Poor
Plant Cell +++ +++ +++ Poor
CHO Cell ++++ ++++ ++++ Non-Human Like
Human Cell +++++ +++++ +++++ Human authentic


2. High Bioactivity & Detection Sensitivity

The bioactivity of biotinylated proteins is determined both by the structure of the protein itself, and by the way how biotinylation is performed. For every single protein, multiple options of tags and biotinylation methods are tested. And the products are evaluated in a variety of binding assays. Only those with the best performance are selected for production. Figure 1 is an example of the internal evaluation experiments.

Activité de liaison de différentes formes de PD-1 biotinylé évaluée dans un ELISA fonctionnel contre rhPD-L1Fig. 1 Binding activity of different forms of biotinylated PD-1 evaluated in a functional ELISA against rhPD-L1 (Cat. No. PD1-H5258 )

These biotinylated proteins demonstrate high bioactivity and superb detection sensitivity in different application. In functional ELISA, the biotinylated human BCMA has high binding activity with BAFF as showed in figure 2. Figure 3 shows that the biotinylated PD-1 can be well applied to AlphaLISA to detect the binding activity with its ligand PD-L2. The figure 4 shows that the biotinylated protein can be easily used for determining the affinity between protein and therapeutic antibody in SPR assay. Also, the biotinylated proteins are often used in cell based assay, such as cytotoxicity assay and evaluation of CAR expression (Fig. 5 & Fig. 10).


BAFF humain immobilisé, Fc TagFig. 2 Immobilized Human BAFF, Fc Tag (Cat. No. BAF-H4268) at 5μg/mL (100μL/well) can bind Biotinylated Human BCMA, Fc Tag Cat.No. BC7-H82F0) with a linear range of 0.12-1.95ng/mL.



PD-1 humain biotinyléFig. 3 Biotinylated Human PD-1 (Cat. No. PD1-H82F1) at 1μg/mL (5μL/well) can bind Human PD-L2 (Cat. No. PD2-H5220) with a linear range of 0.02-0.625μg/mL.



La constante d'affinité de la protéine CD19 humaine est de 0,255 nMFig.4 The affinity constant of human CD19 protein was 0.255nM as verified by SPR Biotinylated Human CD19 (20-291), His,Avitag (Cat. No. CD9-H82E9) captured on Biotin CAP – Series S sensor Chip can bind FMC63 MAb (mouse lgG2a) with an affinity constant of 0.255nM as determined in a SPR assay (Biacore 8K) (QC tested).


Cell based assay

TNF-alpha humain recombinantFig. 5 Recombinant human TNF-alpha (Cat. No. TNA-H82E3) induces cytotoxicity effect on the WEH1-13VAR cells in the presence of the metabolic inhibitor actinomycin D. The EC50 for this effect is 0.014-0.029 ng/ml. The result shows that the biotinylated human TNF-alpha is consistent with naked TNF-alpha in cytotoxicity assay.


Know more: